Dr. Reddy’s launches generic nicorette lozenges in U.S.

Dr. Reddy’s Laboratories (NYSE:RDY) announces the launch of Over-the-Counter (OTC) Nicotine Polacrilex Lozenges, 2 mg and 4 mg in the U.S., the store brand version of GlaxoSmithKline’s Nicorette Lozenges.

The Nicotine Lozenges brands and store brand markets had total U.S. retail sales of ~$200M for the year ended May 17, according to IRI.

https://seekingalpha.com/news/3590865-dr-reddys-launches-generic-nicorette-lozenges-in-u-s